Clinical Trials Browser

INDUSTRY × BCG Vaccine × 90 days × Clear all

NCT06833073 2026-05-28

INTerpath-011

Phase 2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT03711032 2026-05-01

MK-3475-676

Phase 3 Active not recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT05981131 2026-04-29

Follow up of Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive Bladder Cancer (NMIBC)

Active not recruiting

Non-Muscle Invasive Bladder Neoplasms

NCT03528694 2026-04-14

POTOMAC

Phase 3 Active not recruiting

1,018 enrolled 1 FDA

Non-Muscle Invasive Bladder Neoplasms

NCT05037279 2026-03-20

EVER

Phase 3 Recruiting

Urinary Bladder Neoplasms, Recurrence